Hiv

(Image: Getty/Mohd Hafiez Mohd Razali / EyeEm)

WHO indicates preferred HIV treatment

By Vassia Barba

Citing evidence from two completed clinical trials, the WHO recommends dolutegravir as the preferred treatment for all patients with HIV.

(Image: Getty/Nito100)

J&J moves HIV vaccine into US and European trials

By Ben Hargreaves

J&J will test a vaccine candidate for HIV prevention in 3,800 men across the US and Europe, at the same time as ViiV releases positive comparative data on its HIV treatment.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers